Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2
- PMID: 15695404
Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2
Abstract
Breast cancer resistance protein (BCRP)/ABCG2 mediates concurrent resistance to chemotherapeutic agents, such as 7-ethyl-10-hydroxycamptothecin (SN-38), mitoxantrone, and topotecan, by pumping them out of cells. We previously reported that BCRP transports sulfated estrogens. In the present study, we show that at physiologic levels, estrogens markedly decrease endogenous BCRP expression in the estrogen-responsive and estrogen receptor alpha (ERalpha)-positive human breast cancer MCF-7 cells, but not in estrogen-nonresponsive human cancer cells. 17 beta-Estradiol (E(2)) also significantly reduces exogenous BCRP expression, driven by a constitutive promoter, in BCRP-transduced estrogen-responsive and ERalpha-positive MCF-7 (MCF-7/BCRP) and T-47D cells, but not in BCRP-transduced estrogen-nonresponsive MDA-MB-231 and SKOV-3 cells. E(2) potentiates the cytotoxicity of SN-38, but not vincristine, in MCF-7/BCRP cells significantly, and increases cellular topotecan uptake in MCF-7 and MCF-7/BCRP cells. Antiestrogen tamoxifen partially reverses E(2)-mediated BCRP down-regulation in MCF-7 and MCF-7/BCRP cells and treatment of MCF-7/BCRP cells with an ERalpha small interfering RNA abolished E(2)-mediated BCRP down-regulation, suggesting that interaction of E(2) and ERalpha is necessary for BCRP down-regulation. E(2) does not affect endogenous BCRP mRNA levels in MCF-7 cells or exogenous BCRP mRNA levels in MCF-7/BCRP cells. The results from pulse-chase labeling experiments with MCF-7/BCRP cells suggest that decreased protein biosynthesis and maturation, but not alterations in protein turnover, might underlie E(2)-mediated BCRP down-regulation. These data indicate that estrogen down-regulates BCRP expression by novel posttranscriptional mechanisms. This is the first report of small molecules that can affect BCRP protein expression in cells and may therefore assist in establishing new strategies for regulating BCRP expression.
Similar articles
-
[Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):654-60. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 22340044 Chinese.
-
Transcriptional modulation of BCRP gene to reverse multidrug resistance by toremifene in breast adenocarcinoma cells.Breast Cancer Res Treat. 2010 Oct;123(3):679-89. doi: 10.1007/s10549-009-0660-2. Epub 2009 Dec 6. Breast Cancer Res Treat. 2010. PMID: 19967559
-
Transcriptional upregulation of breast cancer resistance protein by 17beta-estradiol in ERalpha-positive MCF-7 breast cancer cells.Oncology. 2006;71(5-6):446-55. doi: 10.1159/000108594. Epub 2007 Sep 17. Oncology. 2006. PMID: 17878748
-
Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).Oncogene. 2003 Oct 20;22(47):7340-58. doi: 10.1038/sj.onc.1206938. Oncogene. 2003. PMID: 14576842 Review.
-
Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development.Cancer Lett. 2006 Mar 8;234(1):73-80. doi: 10.1016/j.canlet.2005.04.039. Epub 2005 Nov 21. Cancer Lett. 2006. PMID: 16303243 Review.
Cited by
-
Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein BCRP/ABCG2.Cancer Sci. 2005 Dec;96(12):866-72. doi: 10.1111/j.1349-7006.2005.00126.x. Cancer Sci. 2005. PMID: 16367905 Free PMC article.
-
ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma.Diagn Pathol. 2011 Sep 27;6:90. doi: 10.1186/1746-1596-6-90. Diagn Pathol. 2011. PMID: 21943250 Free PMC article.
-
Transcription factor-mediated regulation of the BCRP/ABCG2 efflux transporter: a review across tissues and species.Expert Opin Drug Metab Toxicol. 2020 Mar;16(3):239-253. doi: 10.1080/17425255.2020.1732348. Epub 2020 Mar 14. Expert Opin Drug Metab Toxicol. 2020. PMID: 32077332 Free PMC article. Review.
-
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.Br J Cancer. 2009 Feb 10;100(3):476-86. doi: 10.1038/sj.bjc.6604873. Epub 2009 Jan 20. Br J Cancer. 2009. PMID: 19156141 Free PMC article.
-
Discovery of drug transporter inhibitors tied to long noncoding RNA in resistant cancer cells; a computational model -in silico- study.Front Immunol. 2025 Apr 25;16:1511029. doi: 10.3389/fimmu.2025.1511029. eCollection 2025. Front Immunol. 2025. PMID: 40352931 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous